Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
VALERITAS Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 245,05 | -0,04 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
TELADOC HEALTH | 6,470 | -0,40 % | Teladoc Health, Inc.: Teladoc Health Reports First Quarter 2025 Results | PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First... ► Artikel lesen | |
THERMO FISHER | 361,85 | -0,04 % | Cybin Inc (2): Cybin hires Thermo Fisher for phase 3 supply of CYB003 | ||
ROKU | 62,80 | +0,22 % | Roku Analyst Says TV's Future Hinges On This 'Powerful' Cost Saver, But It's Still Early | ||
RESMED | 222,50 | +0,09 % | Resmed, Inc.: Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 | SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the... ► Artikel lesen | |
HENRY SCHEIN | 62,36 | -2,47 % | Aktie von Henry Schein: Kurs mit wenig Bewegung (62,7623 €) | Die Wertschätzung für das Wertpapier von Henry Schein hat sich an der Börse heute kaum geändert. Die Aktie kostete zuletzt 70,15 US-Dollar. Kaum auffällig ist aktuell am Aktienmarkt der Kurs von Henry... ► Artikel lesen | |
ZIMMER BIOMET | 85,56 | -1,04 % | Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish? | ||
SONOMA PHARMACEUTICALS | 3,030 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain | BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
PETMED EXPRESS | 3,320 | 0,00 % | Petmed Express Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
TANDEM DIABETES | 20,320 | +0,10 % | Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set | ||
VERU | 0,450 | -1,19 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
QUIDELORTHO | 29,800 | +0,68 % | SA analyst downgrades: QDEL, AMCX, PLYM, DAY | ||
TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
QUEST DIAGNOSTICS | 158,50 | +0,48 % | Quest Diagnostics declares $0.80 dividend | ||
SENSEONICS | 0,499 | +2,05 % | Senseonics opens $50M public offering, $25M private placement with Abbott |